Discoveries, drugs and skeletal disorders

被引:137
作者
Goltzman, D
机构
[1] McGill Univ, Dept Med, Montreal, PQ H3A 1A1, Canada
[2] McGill Univ, Ctr Hlth, Montreal, PQ H3A 1A1, Canada
关键词
D O I
10.1038/nrd916
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Bone turnover, in which cells of the osteoclast lineage resorb bone and cells of the osteoblast lineage deposit bone, normally occurs in a highly regulated manner throughout life. Perturbations to these processes underlie skeletal disorders, such as osteoporosis, which are common, chronic and disabling, and increase with age. On the basis of empirical observations or on understanding of the endocrinology of the skeleton, excellent bone-resorption inhibitors, but few anabolic agents, have been developed as therapeutics for skeletal disorders. However, powerful new genomic and genetic tools are uncovering new loci that regulate the activity of both osteoclasts and osteoblasts, and these hold great promise for future drug development.
引用
收藏
页码:784 / 796
页数:13
相关论文
共 121 条
[1]   Variations in trabecular bone composition with anatomical site and age: potential implications for bone quality assessment [J].
Aerssens, J ;
Boonen, S ;
Joly, J ;
Dequeker, J .
JOURNAL OF ENDOCRINOLOGY, 1997, 155 (03) :411-421
[2]   Haploinsufficiency of parathyroid hormone-related peptide (PTHrP) results in abnormal postnatal bone development [J].
Amizuka, N ;
Karaplis, AC ;
Henderson, JE ;
Warshawsky, H ;
Lipman, ML ;
Matsuki, Y ;
Ejiri, S ;
Tanaka, M ;
Izumi, N ;
Ozawa, H ;
Goltzman, D .
DEVELOPMENTAL BIOLOGY, 1996, 175 (01) :166-176
[3]   PARATHYROID HORMONE-RELATED PEPTIDE-DEPLETED MICE SHOW ABNORMAL EPIPHYSEAL CARTILAGE DEVELOPMENT ALTERED ENDOCHONDRAL BONE-FORMATION [J].
AMIZUKA, N ;
WARSHAWSKY, H ;
HENDERSON, JE ;
GOLTZMAN, D ;
KARAPLIS, AC .
JOURNAL OF CELL BIOLOGY, 1994, 126 (06) :1611-1623
[4]   Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: Formal histomorphometric and biomechanical analyses [J].
Amling, M ;
Priemel, M ;
Holzmann, T ;
Chapin, K ;
Rueger, JM ;
Baron, R ;
Demay, MB .
ENDOCRINOLOGY, 1999, 140 (11) :4982-4987
[5]   Regulation of Osteoblast Formation and Function [J].
Aubin J.E. .
Reviews in Endocrine and Metabolic Disorders, 2001, 2 (1) :81-94
[6]   Raloxifene and cardiovascular events in osteoporotic postmenopausal women - Four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial [J].
Barrett-Connor, E ;
Grady, D ;
Sashegyi, A ;
Anderson, PW ;
Cox, DA ;
Hoszowski, K ;
Rautaharju, P ;
Harper, KD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (07) :847-857
[7]   Sox9 is required for cartilage formation [J].
Bi, WM ;
Deng, JM ;
Zhang, ZP ;
Behringer, RR ;
de Crombrugghe, B .
NATURE GENETICS, 1999, 22 (01) :85-89
[8]   Bone marrow stromal stem cells: Nature, biology, and potential applications [J].
Bianco, P ;
Riminucci, M ;
Gronthos, S ;
Robey, PG .
STEM CELLS, 2001, 19 (03) :180-192
[9]   Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures [J].
Black, DM ;
Cummings, SR ;
Karpf, DB ;
Cauley, JA ;
Thompson, DE ;
Nevitt, MC ;
Bauer, DC ;
Genant, HK ;
Haskell, WL ;
Marcus, R ;
Ott, SM ;
Torner, JC ;
Quandt, SA ;
Reiss, TF ;
Ensrud, KE .
LANCET, 1996, 348 (9041) :1535-1541
[10]   OSTEOCLASTIC BONE-RESORPTION BY A POLARIZED VACUOLAR PROTON PUMP [J].
BLAIR, HC ;
TEITELBAUM, SL ;
GHISELLI, R ;
GLUCK, S .
SCIENCE, 1989, 245 (4920) :855-857